Entries Tagged as ''

Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association.

Interactions of thyroid hormones; insulin-like growth factor-1 (IGF-1), IGF binding proteins, and nutritional anthropometric parameters in school children with goiter detected by palpation.

Ghrelin treatment increases receptor-bound leptin in healthy and endotoxemic obese Lewis rats.

Counting the cost of type 2 diabetes in Vanuatu.

Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?

Neuropsychological status of elderly patients with diabetes mellitus.

Neuronal Insulin Receptor Substrate (IRS)-2 Expression is Regulated by ZBP89 and SP1 Binding to the IRS-2 Promoter.

BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes

Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.

ESC Events In Asia Tackle Management Of Diabetes And Cardiovascular Disease

With the rapidly increasing problem of cardiovascular (CVD) disease in Asia Pacific (AP), there is an urgency to raise awareness of risk factors. The European Society of Cardiology (ESC) is addressing the need to develop and adopt an integrated approach to CVD management, through important events organised in the region. CVD has become more prevalent in India and China than in all of the economically-developed countries in the world combined.

Placental Precursor Stem Cells Require Testosterone-Free Environment To Survive

Trophoblast stem cells (TSCs), cells found in the layer of peripheral embryonic stem cells from which the placenta is formed, are thought to exhibit "immune privilege" that aids cell survivability and is potentially beneficial for cell and gene therapies. Further, the survivability of TSCs has been thought to require the presence of ovarian hormones. However, none of these assumptions has ever been verified.